Next Article in Journal
Mechanisms and Physiological Roles of the CBL-CIPK Networking System in Arabidopsis thaliana
Next Article in Special Issue
Telomerase Regulation from Beginning to the End
Previous Article in Journal / Special Issue
The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?

Telomerase Activation in Hematological Malignancies

Cutaneous Lymphoma Oncogenesis Team INSERM U1053 Bordeaux Research in Translational Oncology, Bordeaux University, Bordeaux 33076, France
Institute of Biomedical Sciences of Abel Salazar, University of Porto, Porto 4050-313, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto 4200-135, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup)—Cancer Biology, Rua Dr. Roberto Frias, s/n, Porto 4200-465, Portugal
Tumor Bank and Tumor Biology Laboratory, University Hospital Center Bordeaux, Pessac 33604, France
Department of Pathology and Oncology, Medical Faculty of Porto University, Porto 4200-319, Portugal
Author to whom correspondence should be addressed.
Academic Editor: Gabriele Saretzki
Genes 2016, 7(9), 61;
Received: 1 June 2016 / Revised: 15 July 2016 / Accepted: 29 July 2016 / Published: 7 September 2016
(This article belongs to the Special Issue Telomerase Activity in Human Cells)
Telomerase expression and telomere maintenance are critical for cell proliferation and survival, and they play important roles in development and cancer, including hematological malignancies. Transcriptional regulation of the rate-limiting subunit of human telomerase reverse transcriptase gen (hTERT) is a complex process, and unveiling the mechanisms behind its reactivation is an important step for the development of diagnostic and therapeutic applications. Here, we review the main mechanisms of telomerase activation and the associated hematologic malignancies. View Full-Text
Keywords: telomerase activity; hematological malignancy; amplification; epigenetic; polymorphism; mutation; virus telomerase activity; hematological malignancy; amplification; epigenetic; polymorphism; mutation; virus
MDPI and ACS Style

Ropio, J.; Merlio, J.-P.; Soares, P.; Chevret, E. Telomerase Activation in Hematological Malignancies. Genes 2016, 7, 61.

AMA Style

Ropio J, Merlio J-P, Soares P, Chevret E. Telomerase Activation in Hematological Malignancies. Genes. 2016; 7(9):61.

Chicago/Turabian Style

Ropio, Joana, Jean-Philippe Merlio, Paula Soares, and Edith Chevret. 2016. "Telomerase Activation in Hematological Malignancies" Genes 7, no. 9: 61.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop